期刊文献+

中国大陆地区肠杆菌科细菌aac(6')-Ib—cr基因检出率与常见药物不同耐药水平关系的研究 被引量:2

Comparison Study of aac(6')-Ib-cr in Clinical Isolates of Enterobacteriaceae in the Mainland of China
下载PDF
导出
摘要 目的研究中国大陆地区质粒介导的耐药基因aac(6’)-Ib—cr在肠杆菌科细菌环丙沙星和阿米卡星敏感株与耐药株中及在ESBL阳性株和阴性株中的分布状况和比较分析.方法从2006年全国美平耐药监测网点中收集241株非重复的大肠埃希菌和肺炎克雷伯菌,用琼脂对倍稀释法测定所有菌株对环丙沙星等药物的MIC值.采用PCR检测所有菌株的aac(6’)-Ib基因;并以内切酶BtsCI酶切消化aac(6’)-Ib的PCR阳性产物和/或DNA测序以确定aac(6’)-Ib—cr.结果在241株筛选出的大肠埃希菌和肺炎克雷伯菌中,环丙沙星的耐药率为61.4%(148/241);阿米卡星的耐药率为10.0%(24/241);ESBL阳性株占56.8%(137/241).aac(6’)-Ib—cr的总阳性率为12.4%(30/241).经妒检验,aac(6’)-Ib—cr基因在环丙沙星敏感菌株与耐药菌株中的检出率差异具有统计学意义(0.0%和20.3%,X^2=20.655,P〈0.05);在阿米卡星敏感菌株与耐药菌株中约检出率差异无统计学意义(12.0%和16.7%,X^2=0.112,P〉0.05);在ESBL阳性株与ESBL阴性株中的检出率差异无统计学意义(16.1%和7.7%,X^2=3.797,P〉0.05).结论质粒介导喹诺酮类耐药基因aac(6’)-Ib-cr在大肠埃希菌和肺炎克雷伯菌中的分布广泛,而且该基因在环丙沙星敏感菌株与耐药菌株的检出率差异具有统计学意义,而在阿米卡星敏感菌株与耐药菌株中的检出率差异无统计学意义,在ESBL阳性株与阴性株中的检出率亦无统计学意义. Objective To investigate the prevalence of pasmid-mediated quinolone resistance aac(6')-Ib-cr in the clinical isolates of Escherichia coli and Klebsiella pneumoniae in China. Methods All non-repetitive 241 clinical isolates with Escherichia coli and Klebsiella pneumoniae collected from the Chinese Meropenem Susceptibility Surveillance study collection. The MIC of ciprofloxacin and other antibacterial agents were determined by agar dilution. Aac(6')-Ib gene were detected by PCR ,aac (6')-Ib-cr gene was further identified by the digestion with BtsCI and/or direct sequencing. The isolates were divided into two groups according to the resistence level of ciprofloxacin or amikacin and ESBLs. Results In 241 screen Escherichia coli and Klebsiella pneumoniae, resistance of ciprofloxacin was 61.4 % (148/241 ) ; resistance of amikaein was 10. 0%(24/241);producing ESBLs accounts for 56.8%(137/241). Aac(6')-Ib-cr was present in 12.4%(30/241) of isolates. There was significant difference between the two groups (the Susceptibility and resistance for ciprofloxacin) in the prevalence of isolates carrying the aac (6')-Ib-cr genes (0.0 % and 20.3 %,X^2= 20. 655 ,P〈0.05). There was no significant difference between the two groups (the Susceptibility and resistance for amikacin) in the prevalence of isolates carrying the aac (6')-Ib-cr genes (12. 0% and 16. 7 %, X^2= 0. 112, P 〉 0. 05). There was no significant difference between the two groups(producing ESBLs and non-producing ESBLs) in the prevalence of isolates carrying the aac (6')-Ib-cr genes (16. 1% and 7.7% ,X^2=3. 797,P〉0. 05). Conclusion The plasmid-mediated aac(6' )-Ib-cr widely existed in the Escherichia coli and Klebsiella pneumoniae strains in China. And there is significant difference between the two groups (the Susceptibility and resistance for ciprofloxacin) in the prevalence of isolates carrying the aac(6' )-Ib-cr genes, and there is no significant difference between the two groups (the Susceptibility and resistance for amikacin,as well as producing ESBLs and non-producing ESBLs)in the prevalence of isolates carrying the aac(6' )-Ib-cr genes.
出处 《现代检验医学杂志》 CAS 2009年第2期25-28,共4页 Journal of Modern Laboratory Medicine
关键词 大肠埃希菌 肺炎克雷伯菌 质粒介导耐药 喹诺酮类 aac(6’)-Ib—cr Enterobacteriaceae Klebsiella pneumoniae plasmid-mediated resistance quinolones aac(6')-Ib-cr
  • 相关文献

参考文献10

  • 1Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones [J]. Clin Infect D/s,2000,31 (suppl 2):24-28.
  • 2Martinez-Martinez L, Paseual A, Jacoby GA. Quinolone resistance from a transferable plasmid [J]. Lancet,1998,351:797-799.
  • 3Hata M,Suzuki M,Matsumoto M ,et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b [J ]. Antimicrob Agents Chemother, 2005,49(2) : 801-803.
  • 4Jacoby GA ,Walsh KE,Mills DM ,et al. QnrB,another plasmid-mediated gene for quinolone resistance [J]. Antimicrob Agents Chemother, 2006, 50 (4):1178-1182.
  • 5Robicsek A,Strahilevitz J, Jacoby GA,et al. Fluoroquinolone modifying enzyme:a new adaptation of a common aminoglycoside aeetyltransferase [J]. Nat Med, 2006,12 : 83-88.
  • 6Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. CLSI M100-S17 [S]. Clinical and Laboratory Standards Institute, Wayne ,PA. 2007.
  • 7Park CH,Robicsek A,Jacoby GA,et al. Prevalellee in the United States of aac (6 ')-Ib-cr encoding a ciprofloxacin-modifying enzyme [J]. A.ntimicrob Agents Chemother, 2006,59(11) : 3953-3955.
  • 8余方友,杜卫良,李国安,李美兰,张雪青,石亮,陈增强.肺炎克雷伯菌临床分离株aae(6′)-Ib-cr基因的检测[J].中华检验医学杂志,2008,31(9):975-978. 被引量:4
  • 9Jian-Hua Liu, Yu-Ting Deng, Zhen-Ling, et al. Cop- revalence of Plasmid-Mediated Quinolone Resistance Determinants QepA, Qnr, and AAC (G ' )-Ib-er among 16S rRNA Methylasz RmtB-Produeing Escherichia coli Isolates from Pigs [J]. Antimicrob Agents Chemother, 2008,52 : 2292-2293.
  • 10Lavigne JP,Marchandin H,Delmas J,et al. CTX-M β-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors[J]. J Clin Microbiol, 2007,45 : 620-626.

二级参考文献7

  • 1吕霞,李从荣.质粒介导的喹诺酮耐药qnr基因的检测[J].中国感染与化疗杂志,2007,7(1):58-60. 被引量:10
  • 2Robicsek A, Strahilevitz J, Jacoby GA, et al. Fluoroquinolonemodifying enzyme:a new adaptation of a common aminoglycoside acetyltransferase. Nat Med, 2006, 12:83-88.
  • 3Park CH, Robicsek A, Jacoby GA, et al. Prevalence in the United States of aac (6')-Ib-cr encoding a ciprofloxacinmodifying enzyme. Antimicrob Agents Chemother, 2006, 50:3953-3955.
  • 4Clinical and Laboratory Standards Institute. M100-S17 Performance standards for antimicrobial susceptibility testing, 17th informational supplement . 2006 .
  • 5Ambrozic Avgustin J, Keber R, Zerjavic K, et al. Emergence of the quinolone resistance-mediating gene aac (6')-Ib-cr in extended-spectrum-beta-lactamase-producing Klebsiella isolates collected in Slovenia between 2000 and 2005. Antimicrob Agents Chemother, 2007,51 : 4171- 4173.
  • 6Quiroga MP, Andres P, Petroni A, et al. Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical Enterobacterial isolates from argentina. Antimicrob Agents Chemother, 2007,51: 4466-4470.
  • 7Xu X, Wu S, Ye X, et al. Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1. Antimicrob Agents Chemother, 2007, 51:4105-4110.

共引文献3

同被引文献21

  • 1刘丁,陈萍,李玉红,杨程.多重PCR检测鲍曼不动杆菌氨基糖苷乙酰转移酶相关基因[J].第三军医大学学报,2006,28(23):2320-2322. 被引量:5
  • 2Park CH,Robicsek A,Jacoby GA,et aI.Prevalence in the united states of aac (6')-Ib-cr encoding a ciprofloxacin- modifying enzyme [ J ].Antimicmb Agents Chemother, 2006,50 ( 11 ) : 3953-3955.
  • 3Robicsek A ,Strahilevitz J,Jacoby GA,et al.Fluoroquinolone modifying enzyme : a new adaptalion of a comxnon aminoglycoside acetyltransferase [J].Nal Med, 2006, 12 ( 1 ) : 83- 88.
  • 4Livermore DM. Has the era of untreatable infections arrived? [ J]. J Antimicrob Chemother, 2009, 64(1 ): 29-36.
  • 5Morgan- Linnell SK, Becnel Boyd L, Steffen D, et al. Mecha- nisms accounting for fluoroquinolone resistance in Escheriehia coli clinical isolates[J]. Antimicrob Agents Chemother, 2009, 53( 1 ) : 235 - 241.
  • 6Strahilevitz J, Jacoby GA, Hooper DC, et al. Plasmid - mediated quinolone resistance: a multifaeeted threat [ J ]. Clin Mierobiol Rev, 2009, 22(4): 664-689.
  • 7Robicsek A, Strahilevitz J, Sahm DF, et al. qnr prevalence in cefta- zidime- resistant Enterebacteriaceae isolates from the United States [J]. Antimicreb Agents Ch, 2006, 50(8) : 2872-2874.
  • 8Park CH, Robicsek A, Jaeoby GA, et al. Prevalence in the United States of aac (6') - Ib - cr encoding a ciprofloxacin - modifying en- zyme [ J]. Antimicrob Agents Ch, 2006, 50 ( 11 ) : 3953 - 3955.
  • 9Ling TK, Xiong J, Yu Y, et al. Multicenter antimicrebial suscepti- bility survey of Gram - negative bacteria isolated from patients with community- acquired infections in the People's Republic of China r J]. Antimicreb A,ents Ch. 2006. 50( 1 ) : 374- 378.
  • 10Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes [J]. Drug Resist Updat, 2010, 13(6) : 151 -171.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部